CD180
Aliases: | LY64, Ly78, RP105 |
---|---|
Other: | CD180 antigen|lymphocyte antigen 64|lymphocyte antigen-64, radioprotective, 105kDa|radioprotective 105 kDa protein |
CD180 is a cell surface molecule consisting of extracellular leucine-rich repeats (LRR) and a short cytoplasmic tail. The extracellular LRR is associated with a molecule called MD-1 and form the cell surface receptor complex, RP105/MD-1. It belongs to the family of pathogen receptors, Toll-like receptors (TLR). RP105/MD1, by working in concert with TLR4, controls B cell recognition and signalin... see more
PE-Vio770
Common Laser: | 488-561 |
---|---|
Common Filter: | 780/60 |
Excitation Peak: | 565 |
Emission Peak: | 775 |
PE-Vio® 770 from Miltenyi Biotec is a red-emitting tandem fluorophore that combines pycoerythrin (PE) and Vio®770. The donor molecule, PE can be excited by the 488-nm blue, 532-nm green, or 561-nm yellow-green laser and and transfers energy to the acceptor molecule, Vio®770, which emitts light that can be captured with a 780/60 nm bandpass filter. PE-Vio®770 has an excitation peak at 565 nm and... see more
Popular CD180 PE-Vio770 Antibodies
Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
---|---|---|---|---|---|---|
Miltenyi Biotec 130-115-850 |
FC | CD180 Human |
Human IgG1 REA956 |
100 tests in 200 µL $355 |
Details | |
Miltenyi Biotec 130-115-931 |
FC | CD180 Mouse |
Human IgG1 REA957 |
30 µg in 200 µL $156 |
Details | |
Miltenyi Biotec 130-115-922 |
FC | CD180 Human |
Human IgG1 REA956 |
30 tests in 60 µL $164 |
Details | |
Miltenyi Biotec 130-103-102 |
FC | CD180 Mouse |
Rat IgG2a κ RP/14 |
9 μg in 30 μl $57 |
Details | |
Miltenyi Biotec 130-102-333 |
FC | CD180 Mouse |
Rat IgG2a κ RP/14 |
30 μg in 1 ml $167 |
Details | |
Miltenyi Biotec 130-115-859 |
FC | CD180 Mouse |
Human IgG1 REA957 |
150 µg in 1 mL $450 |
Details | |
Miltenyi Biotec 130-098-492 |
FC | CD180 Human |
Mouse IgG1 κ MHR73-11 |
100 Tests in 1 ml $350 |
Details | |
Browse CD180 / PE-Vio770 antibodies. |